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Parkinson s´ disease (PD) is the second most common 
neurodegenerative disorder. It aff ects over half a million 
individuals in the U.S., with another 50,000 diagnosed 
every year. PD is characterized by motor dysfunction 
caused by a progressive loss of dopaminergic neurons. 
Currently, there are no treatments that slow the progression 
of the disease, which highlights the need for the 
development of new therapies.
High content screening (HCS) is a drug discovery method 
that could be leveraged in cellular models of PD to assess the 
therapeutic viability of thousands of compounds. However, 
HCS is challenging as it requires rapid analysis of large 
volumes of data from images of fl uorescently labeled cells. 
In our study, carried out in the laboratory of Dr. Chris 
Rochet, we are developing an automated protocol for 
use in HCS. Our HCS will monitor cellular uptake of 
fl uorescently labeled, misfolded protein aggregates called 
fi brillar seeds, which promote protein accumulation and 
clumping. Fibrillar seeds are believed to be the species 
responsible for the propagation of neuropathology in the 
brains of PD patients by inducing abnormal protein folding 
and aggregation in neurons, as is also true for other 
neurodegenerative diseases. Synthetic preformed fi brils 
(PFFs) labeled with fl uorescent tags are administered 
to neuron cell cultures, and specifi c uptake of these 
fi brils in primary midbrain neurons is monitored (see 
image). Recent plugins developed within ImageJ, an 
image analysis program, have been used to automatically 
recognize regions of co-localized fl uorescence and 
calculate average intensity from these regions. We are 
designing fl uorescence-based methods and image analysis 
plugins that can be used to visualize and quantify the 
presence of PFFs in the interior of the cell. Our HCS 
approach will be used to identify protective compounds 
with the potential to prevent PD progression. 
Graduate student mentor Sayan Dutta writes: “Ryan’s 
research addresses a key piece of a bigger puzzle of fi nding 
eff ective drug molecules to slow down Parkinson’s disease. 
His current eff orts in designing a fl uorescent probe and 
image analysis algorithm are making our high content 
screening project move forward signifi cantly.”
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Evidence of aSyn PFF uptake in primary midbrain neurons. (Left) Transmission electron microscopy images of fibrils formed by 
unmodified human WT aSyn; scale bar = 200 nm. (Right) Primary midbrain cultures transduced with virus-encoding RFP downstream of 
the neuron-specific synapsin promoter were treated with PFFs derived from recombinant human WT aSyn labeled with Alexa 488. After 
24 hrs, the cultures were treated with trypan blue for 15 min to quench extracellular fluorescence and imaged via confocal microscopy. 
Green fluorescent puncta corresponding to internalized, Alexa 488-labeled aSyn were detected in neurons that appear red because of 
RFP expression (the yellow color corresponds to colocalized green and red signals). (Image retrieved with help of Dr. Ranjan Sengupta 
and Sayan Dutta.)
